Parallel synthesis of bis-heterocyclic isoxazolylmethyl- And isoxazolinylmethylpyrazoles

Journal of Combinatorial Chemistry

Volumn 12, Issue 1, 2010, Pages 129-136

  Meng, Liping ^a   Lorsbach, Beth A ^b   Sparks, Thomas C ^b   Fettinger, James C ^a   Kurth, Mark J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DOW AGROSCIENCES LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; HETEROCYCLIC COMPOUND; OXADIAZOLE DERIVATIVE; PYRAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; METHODOLOGY; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

COMBINATORIAL CHEMISTRY TECHNIQUES; CRYSTALLOGRAPHY, X-RAY; HETEROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; OXADIAZOLES; PHARMACEUTICAL PREPARATIONS; PYRAZOLES; STEREOISOMERISM;

EID: 74049124899     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc900133k     Document Type: Article

References (57)

1. (a) Mayer, S. C.; Banker, A. L.; Boschelli, F.; Di, L.; Johnson, M.; Kenny, C. H.; Krishnamurtliy, G.; Kutterer, K.; Moy, F.; Petusky, S.; Ravi, M.; Tkach, D.; Tsou, H.-R.; Xu, W. Bioorg. Med. Chem, lett. 2008, 18, 3641-3645.
2. (b) Yang, X.; Parker, D.; Whitehead, L.; Ryder, N. S.; Weidmann, B.; StabileHarris, M.; Kizer, D.; McKinnon, M.; Smellie, A.; Powers, D.Comb. Chem. High Throught Screening 2006, 9 123-130.
3. (c) Terrett, N. K. Combinatorial Chemistry; Oxford University Press: New York, 1998; pp 1-184.
4. (d) Dolle, R. E. J. Comb. Chem, 2000, 2, 383-433.
5. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Acc. Chem. Res. 1996, 29, 144-154
6. (f) Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135-8173
7. Dolle, R. E.; Le Bourdonnec, B.; Goodman, A. J.; Morales, G. A.; Thomas, C. J.; Zhang, W. J., Comb, Chem. 2008, 10, 753-802.
8. For an on-line listing of the top fifty prescription drugs, see: http://flndarticles.com/p/articles/mi-hb3007/is-14-30/ai-n28568130.
9. 2-pyrazole as Factor Xa inhibitors: Quan. M. L.; Ellis. C. D.; He, M. Y.; Liauw, A. Y.; Lam, P. Y. S.; Rossi, K. A.; Knabb, R. M.; Luettgen, J. M.; Wright, M. R.; Wong, P. C.; Wexler, R. R. Bioorg. Med. Chem. Lett. 2003, 13, 1023-1102 As herbicides and plant growth regulators,
10. (b) Seitz, T.; Willms. L.; Auler. T.; Bieringer, H.; Thuerwaechter, F. PCT Int. Appl. WO 2001032636, 2001.
11. (c) Willms, L.; Van Almsick, A.; Bieringer, H.; Auler, T.; Thuerwaechter, F. PCT Int. Appl. WO 2001007422, 2001.
12. 2-pyrazole as endothelin antagonists: Zhang, J.; Didierlaurent, S.; Fortin, M.; Lefrancois, D.; Uridat, E.; vevert, J. P. Bioorg, Med, Chem, Lett. 2000,10,2575-2578.
13. (b) Fortin, M.; Zhang, J. PCT Int. Appl. WO 9612706, 1996. As hypoglycemic and hypolipidemic agents,
14. (c) Momose, Y.; Maekawa, T.; Odaka, H.; Kimura, H. PCT Int. Appl. WO 2001038325, 2001. As androgen receptor antagonists,
15. (d) Ito, M.; Suzaki, T.; Yamamoto, S. PCT Int. Appl. WO 2009028543, 2009. As A2B adenosine receptor antagonists,
16. (e) Kalla, R.; Perry, T.; Elzein, E.; Vardhedkar, V.; Li, X.; Ibrahim, P.; Palle, V.; Xiao, D.; Zablocki. J.; Zhong, H.; Zeng, D. PCT Int. Appl. WO 2009088518, 2009. As ALXR receptor agonists,
17. (f) Bur, D.; Corminboeuf, O.; Cren, S.; Fretz, H; Grisostomi, C.; Leroy, X.; Pothier, J.; Richard-Bildstein, S. PCT Int. Appl. WO 2009077954, 2009. As progesterone receptor antagonists,
18. (g) Bradley, P. A.; Dack, K. N.; Marsh, I. R. PCT Int. Appl. WO 2006111856. 2006.
19. El-Badri, M. H.; Kurth, M. J. J. Comb. Chem, 2009.11, 228-238.
20. Carpenter, R. D.; DeBerdt, P. B.; Holden, J. B.; Milinkevich, K. A.; Min, T.; Willenbring, D.; Fettinger, J. C; Tantillo, D. J.; Kurth, M. J. J., comp, Chem. 2008, 10, 225-229.
21. Choung, W.; Lorsbach, B. A.; Sparks, T. C; Ruiz, J. M.; Kurth, M. J. Synlett 2008, 19, 3036-3040.
22. Jeddeloh, M. R.; Holden, J. B.; Nouri, D. H.; Kurth, M. J. J. Comb: Chem. 2007, 9, 1041-1045.
23. Robins, L. I.; Fettinger, J. C.; Tinti, D. S.; Kurth, M. J. J. Comb. Chem. 2007, 9, 139-142.
24. Ge, Y. Q.; Dong, W. L.; Xia, Y.; Wei, F.; Zhao, B. X. Acta Crystallogr. 2007, E63, 1313-1314.
25. (a) There are numerous examples of regioselective pyrazole N-alkylation. Representative examples include: Kost, A. N.; Grandberg, I. I. Adv. Heterocvcl. Chem. 1966, 6, 347-429.
26. (b) Behr, L. C.; Fusco, R.; Jarboe, C. H. Pyrazoles. In Heterocyclic Compounds: Pyrazoles, Pyrazolines, Pyrazolidines, Indazoles and Condensed Rings; WileyR. H., Ed.; Interscience Publishers: New York, 1967; pp 4-73.
27. (c) Grimmett, M. R.; Lim, K. H. R.; Weavers, R. T. Aust, J. Chem. .1979, 32, 2203-2213.
28. (d) Faucher, N. E.; Martres, P. PCT Int. Appl. WO 2005049578, 2005.
29. (e) Allen, J. R.; Hitchcock, S. A.; Liu, B.; Turner, W. W., Jr. PCT Int. Appl. WO 2005009941, 2005.
30. (a) Gonzales-Gomez, A.; Anorhbe, L.; Poblador, A.; Doninguez, G.; Perez-Castells, J. Eur. J. Org. Chem, 2008, 8, 1370-1377.
31. (b) Nilsson, B. M.; Ringdahl, B.; Hacksell, U.J. Med. Chem. 1990, 33, 580-584.
32. (c) Garud, D. R.; Ando. H.; Kawai, Y.; Ishihara, H.; Koketsu, M. Org, lett. 2007, 9, 4455-4458.
33. Rao. A. K. S. B.; Rao, C. G.; Singh. B. B. J. Chem, Res., Synopses 1993, 12, 506-507.
34. (a) There are numerous examples of this strategy for regioselective pyrazole formation. Representative examples include: Stanovnik, B.; Svete, J. Sci Synth 2002, 12, 15-225.
35. (b) McClure, K.; Hack, M.; Huang, L.; Sehon, C.; Morton, M.; Li, L.; Barrett, T. D.; Shankley, N.; Breitenbucher, J. G. Bioorg. Med. Chem. Lett. 2006, 16, 72-76.
36. (c) Myrray, W. V.; Wachter, M. P. J., Heterocyclic Chem 1989, 26, 1389-1392.
37. (d) Liang, J. T.; Mani, N. S.; Jones, T. K. J. Org. Chem. 2007, 72, 8243-8250.
38. (e) Hamanaka, E. S.; Guzman-Perez, A.; Ruggeri, R. B.; Wester, R. T.; Mularski, C. J. PCT Int. Appl. WO 9943663,1999.
39. (f) Breinlinger, E. C.; Cusack, K. P.; Hobson, A. D.; Li, B.; Gordon, T. D.; Stoffel, R. H.; Wallace, G. A.; Gronsgaard, P.; Wang, L. PCT Int. Appl. WO 2009011850, 2009.
40. (a) Kozikowski, A. P. Acc. Chem. Res. 1984, 17, 410-416.
41. (b) Caramella, P.; Grunanger, P. Nitrile oxides and imines. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; Wiley-Interscience Publication: New York, 1984; pp 292-356.
42. Milinkevich, K. A.; Ye, L.; Kurth, M. J.J. Comb. Chem. 2008, 10, 521-525.
43. Fustero, S.; Roman, R.; Sanz-Cervera, J. F.; Simon-Fuentes , A.; Bueno, J.; Villanova, S. J. Org. Chem. 2008, 73, 8545-8552.
44. Dixon, S. M.; Milinkevich, K. A.; Fujii, J.; Liu, R.; Yao, N.; Lam, K. S.; Kurth, M. J. J. Comb Chem. 2007, 9, 143-157.
45. Sammelson, R. E.; Miller, B. R.; Kurth, M. J.J. Org. Chem. 2000, 65, 2225-2228.
46. (a) Kanemasa, S.; Mlatsuda, H.; Kamimura, K.; Kakinami, T. Tetrahedron 2000. 56, 1057-1064.
47. (b) Casnati, G.; Ricca, A. Tetrahedron Lett.1967, 4, 327-330.
48. Butler, J. D.; Solano, D. M.; Robins, L. I.; Haddadin, M. J.; Kurth, M. J. J., Org, Chem. 2008, 73, 234-240.
49. Kang, K. H.; Pae, A. N.; Choi, K. I.; Cho, Y. S.; Chung, B. Y.; Lee, J. E.; Jung, S. H.; Koh, H. Y.; Lee, H. Tetrahedron Lett2001, 42, 1057-1060.
50. Varano, F.; Catarzi, D.; Colotta, V.; Calabri, F. R.; Lenzi, O.; Filacchioni, G.; Galli, A.; Costagli, C.; Deflorian, F.; Moro, S. Bioorg. Med. Chem. 2005, 13, 5536-5549.
51. Meng, L.; Fettinger, J. C.; Kurth, M. ,J. Org. lett. 2007, 9, 5055-5058.
52. (a) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drue Delivery Rev. 2001, 46, 3-26.
53. (b) Lipinski, C. A. Drue Discovery Today: Technol, 2004, 1, 337-341.
54. (c) Keller, T. H.; Picho ta, A.; Yin, Z. Curr. Opin. Chem. Biol. 2006, 10, 357-361.
55. Tice, C. M. Pest Manase, Sci. 2001, 57, 3-16.
56. Milinkevich. K. A.; Yoo. C. L.; Sparks, T. C.; Lorsbach, B. A.; Kurth, M. J, Bieerg, Med. Chem, Lett. 2009, 19, 5796-5798.
57. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Anal. Biochem. 1970, 34, 595-598.